Matches in Nanopublications for { ?s ?p "[Metformin has been used as first-line treatment in patients with type 2 diabetes, and is reported to reduce cancer risk and progression by activating the liver kinase B1 (LKB1)-AMP-activated protein kinase (AMPK) pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP894713.RAuApa2gKGgAwAXbuWwSkLrtU4KJi2bbvphHon2Tzksqc130_assertion description "[Metformin has been used as first-line treatment in patients with type 2 diabetes, and is reported to reduce cancer risk and progression by activating the liver kinase B1 (LKB1)-AMP-activated protein kinase (AMPK) pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP894713.RAuApa2gKGgAwAXbuWwSkLrtU4KJi2bbvphHon2Tzksqc130_provenance.
- NP719518.RAWaXpaL4l5cR-xrPh8LSWf6eeDhOVeYkpnoSr2OK_6Vo130_assertion description "[Metformin has been used as first-line treatment in patients with type 2 diabetes, and is reported to reduce cancer risk and progression by activating the liver kinase B1 (LKB1)-AMP-activated protein kinase (AMPK) pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP719518.RAWaXpaL4l5cR-xrPh8LSWf6eeDhOVeYkpnoSr2OK_6Vo130_provenance.
- NP625813.RAPNj7O-8AtzGbkoGN4NPVAvgisecOw4DoX15DNZZVsm8130_assertion description "[Metformin has been used as first-line treatment in patients with type 2 diabetes, and is reported to reduce cancer risk and progression by activating the liver kinase B1 (LKB1)-AMP-activated protein kinase (AMPK) pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625813.RAPNj7O-8AtzGbkoGN4NPVAvgisecOw4DoX15DNZZVsm8130_provenance.
- NP719822.RAt_uWX3ypwwvy3IcfRUoInR-fPi5ivlUldmwbY_JudOw130_assertion description "[Metformin has been used as first-line treatment in patients with type 2 diabetes, and is reported to reduce cancer risk and progression by activating the liver kinase B1 (LKB1)-AMP-activated protein kinase (AMPK) pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP719822.RAt_uWX3ypwwvy3IcfRUoInR-fPi5ivlUldmwbY_JudOw130_provenance.
- NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_assertion description "[Metformin has been used as first-line treatment in patients with type 2 diabetes, and is reported to reduce cancer risk and progression by activating the liver kinase B1 (LKB1)-AMP-activated protein kinase (AMPK) pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1063128.RABc1pvpc9J7l2SWm1d2KvVrGcP7qve7cLNIH9rOYdBfo130_provenance.